Fortrea Holdings Inc. logo FTRE - Fortrea Holdings Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 5
HOLD 6
SELL 1
STRONG
SELL
0
| PRICE TARGET: $17.40 DETAILS
HIGH: $20.00
LOW: $14.00
MEDIAN: $18.00
CONSENSUS: $17.40
DOWNSIDE: 0.68%

About Fortrea Holdings Inc. (https://www.fortrea.com)

Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.

Key Executives

NAME TITLE DOB SALARY
Anshul Thakral Chief Executive Officer & Director 1978 $1,686,897 USD
Jason F. Knoblauch Chief Financial Officer 1981 $817,879 USD
Jill McConnell Chief Financial Officer 1974 $817,879 USD
Mark A. Morais Chief Operating Officer & President of Clinical Services 1977 $812,667 USD
Agnieszka Gallagher General Counsel & Corporate Secretary 1974
Alejandro Martinez Galindo Chief Information Officer
Dave Cooper Chief Administrative Officer
Drayton Virkler President & Chief Commercial Officer
Hima Inguva Head of Corporate Development
Leonard Scott Dove President of Clinical Pharmacology Services 1974
Oren J. Cohen Chief Medical Officer 1961
Robert Parks Chief Accounting Officer
Sandy Kennedy Chief Quality, Regulatory Affairs & Sustainability Officer
Tracy H. Krumme Senior Vice President of Investor Relations 1968

Company Peers

Peer analysis pending, check back in 1-2 minutes.